|
Deadline Looms on India’s Price Control Expansions for Generics
India’s Group of Ministers on pharmaceutical pricing has until Thursday to decide on how far it will widen its price controls on generic drugs under its National List of Essential Medicines, and how to set those prices, an expert says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives